Lets certain foreign-approved drugs and devices get to U.S. patients faster.
This bill would create a new way for certain drugs, biological products, and medical devices to be sold in the U.S. faster. If these products are already approved in specific trusted foreign countries or the United Kingdom, they could get U.S. marketing approval more quickly. This could give American patients earlier access to treatments, especially for unmet medical needs.
Today, all drugs, biological products, and medical devices must go through the full U.S. FDA approval process, even if they are already approved in other developed countries. This bill would create a new, faster pathway where products already lawfully marketed in specific foreign countries or the United Kingdom could be deemed approved in the U.S. if they meet certain safety and public need criteria.
S 3081 · 119th Congress · October 30, 2025 · AI Summary by gemini-2.5-flash · 7/10
Sign in to see your representatives' phone numbers